|本期目录/Table of Contents|

[1]张玉石,周晓雨,汪应瑞.黛力新治疗慢性偏头痛效果观察[J].慢性病学杂志,2016,(02):139-142.
　ZHANG Yu-shi,ZHOU Xiao-yu WANG Ying-rui.Clinical effect of Deanxit in the treatment of Chronic Migraine[J].,2016,(02):139-142.
点击复制

黛力新治疗慢性偏头痛效果观察(PDF)

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:
期数:
2016年02期
页码:
139-142
栏目:
论著
出版日期:
2016-05-09

文章信息/Info

Title:
Clinical effect of Deanxit in the treatment of Chronic Migraine
作者:
张玉石; 周晓雨; 汪应瑞
三峡大学仁和医院神经内科，湖北宜昌443000
Author(s):
ZHANG Yu-shi;  ZHOU Xiao-yu WANG Ying-rui
Dept.of Neurolog. Renhe Hospital, Three Gorges University, Yichang 443001, China Corresponding author: WANG Ying-rui; E-mail: wyryouxiang@163.com
关键词:
慢性偏头痛; 黛力新; 规范化治疗
Keywords:
Chronic Migraine;  Deanxit;  Standard therapy
分类号:
R747.2
DOI:
-
摘要:
目的探讨黛力新在慢性偏头痛治疗中的临床价值及慢性偏头痛的规范化治疗的重要性。方法 选择符合慢性偏头痛入选标准的83 例患者随机分为黛力新组（黛力新+规范化治疗药物组，n=42） 和普通 组（规范化治疗药物组，n=41），规范化治疗包括急性期对症止痛治疗以及缓解期以西比灵为代表的预防 治疗，分别记录治疗前及治疗后第2、4、6、8 周末患者每周头痛发作次数、每次发作持续时间及疼痛程 度，同时记录不良反应情况。用SPSS 17.0 统计软件进行统计分析，根据情况分别进行t 检验、χ2 检验， P<0.05 为差异有统计学意义。结果两组治疗前后比较治疗总有效率比较， 差异均有统计学意义（P< 0.05），黛力新组8 周末头痛发作次数、每日发作时间减少较普通组更为显著，头痛程度显著减轻，有效率 优于普通组，差异有统计学意义（P<0.05）。黛力新组出现头晕、口干、嗜睡等不良反应的发生率分别为 7.1%，4.7%，2.4%，均可耐受，在用药1 周内自行消失。结论规范化治疗慢性偏头痛是有效的，加用黛 力新联合治疗可能具有更好的临床疗效，黛力新药物安全有效，其不良反应少见，且一般都能耐受。
Abstract:
Objective To observe the clinical effect of Deanxit in the treatment of Chronic Migraine, and to discuss the importance of treatment standardization. Methods 83 patients with chronic migraine collected from our hospital were randomly divided into Deanxit group（Deanxit + standard therapy）and control group（standard therapy）. Standard therapy contain symptomatic therapy in acute stage and prevention therapy In remission. In 2, 4, 6, 8 weeks end follow-up, the occurrence of migraine was observed（ attack frequency, intensity, time of onset, and ADR）. Results Compare before treatment with After treatment, there were statistical significance in the improvement of migraine in both groups（P< 0.05）. After 8 weeks end of treatment，there was statistical significance in the improvement of migraine between Deanxit group and control group（P<0.05）.Total effective rate of Deanxit group was higher than that of control group（P<0.05）. Conclusions Standard therapy is important in the treatment of chronic migraine. Deanxit is effective in the treatment of chronic migraine withless ADR.

参考文献/References:

[1] Lipton RB, Bigal NE, Diamond M, et al. Migraine:prevalence,disease burden,and the need for preventive therapy[J]. Neurol? ogy, 2007(68):343-349.
[2] 郭述苏.中国偏头痛流行病学调查[J].临床神经病学杂志,1991, 4(2):65-67.
[3] Headache Classification Committee of International Headache? Society Classification and diagnostic criteria or headache disor? ders,cranial neuralgias and facialpain[J]. Cephalagia, 1998,8 (7):1-96.
[4] Bussone G, Baldini SD, Andrea G, et al. Nimodlipine versus flunarizine in common migraine:acontrolled pilottrial[J]. Head? ache, 1987,27(2):76-79
[5] 覃静,吴煦东,张微.黛力新联合西比灵治疗偏头疼疗效观察[J]. 中国健康心理学杂志,2008,16(11):1270-71.
[6] Bigal M, Serrano D, Reed M, et al. Chronic migraine in the population:burden， diagnosis， and satisfaction with treatment [J]. Neurology, 2008, 71(8):559-566.
[7] Blumenfeld AM, Varon SF, Buse DC, et al. Disability, HRQOL and resource use among chronic and episodic mi? graineurs:results from the international burden of migraine study (IBMS) [J]. Cephalalgia, 2011,31(3):301-315．
[8] Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine report of an EFNS task force[J]. EurJ Neurol, 2006, 13(6):560-572.
[9] 李舜伟,李焰生,刘若卓,等.中国偏头痛诊断治疗指南[J].中国 疼痛医学杂志,2011,17(2):65-86．
[10 ] 赵海宁,李军,朱燕,等.难治性三叉神经痛的药物联合治疗[J]. 中国疼痛医学杂志,2004,10(2):69-70.

备注/Memo

备注/Memo:
作者简介：张玉石，硕士，主治医师，研究方向：神经内 科 通信作者：汪应瑞，E-mail: wyryouxiang@163.com
更新日期/Last Update: 2016-04-27